Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR SUPPRESSING OR TREATING SYMPTOMS ACCOMPANYING PSEUDO-ALLERGIC REACTIONS
Document Type and Number:
WIPO Patent Application WO/2023/190826
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing, suppressing, or treating the symptoms that accompany pseudo-allergic reactions, said pharmaceutical composition comprising, as an active ingredient, a compound having a P2X4 receptor antagonist action or a pharmaceutically acceptable salt of this compound.
Inventors:
MATSUOKA ISAO (JP)
ITO MASA-AKI (JP)
YOSHIDA KAZUKI (JP)
IMAI TOSHIYASU (JP)
ITO MASA-AKI (JP)
YOSHIDA KAZUKI (JP)
IMAI TOSHIYASU (JP)
Application Number:
PCT/JP2023/013084
Publication Date:
October 05, 2023
Filing Date:
March 30, 2023
Export Citation:
Assignee:
TAKASAKI UNIV OF HEALTH AND WELFARE (JP)
NIPPON CHEMIPHAR CO (JP)
NIPPON CHEMIPHAR CO (JP)
International Classes:
A61K45/00; A61K31/551; A61P1/00; A61P1/06; A61P1/08; A61P1/12; A61P7/10; A61P9/00; A61P9/02; A61P9/06; A61P11/00; A61P11/04; A61P11/16; A61P17/00; A61P17/04; A61P25/00; A61P25/04; A61P37/00
Domestic Patent References:
| WO2022030428A1 | 2022-02-10 |
Foreign References:
| JP2018528159A | 2018-09-27 | |||
| JP2019519484A | 2019-07-11 |
Other References:
KAZUKI YOSHIDA, SHOTA TANIHARA, YUKI MIYASHITA, KOSUKE OBAYASHI, MASAAKI ITO, ISAO MATSUOKA: "[26M-am05] P2X4 receptor signaling enhanced pseudoallergyc response", ABSTRACTS OF ANNUAL MEETING OF PHARMACEUTICAL SOCIETY OF JAPAN (CD-ROM), PHARMACEUTICAL SOCIETY OF JAPAN, JP, vol. 142, 4 March 2022 (2022-03-04) - 28 March 2022 (2022-03-28), JP , XP009549973, ISSN: 0918-9823
Attorney, Agent or Firm:
ASAKURA Eiji et al. (JP)
Download PDF:
Previous Patent: SEALING DEVICE
Next Patent: PH-DEPENDENT ANTI-SULFATED GLYCOSAMINOGLYCAN ANTIBODY AND ANTIBODY-DRUG CONJUGATE
Next Patent: PH-DEPENDENT ANTI-SULFATED GLYCOSAMINOGLYCAN ANTIBODY AND ANTIBODY-DRUG CONJUGATE